Primary brain metastases of endometrial cancer

A report of 18 cases and review of the literature

Stefano Uccella, Jonathan M. Morris, Francesco Multinu, William Arthur Cliby, Karl C. Podratz, Bobbie S. Gostout, Sean Christopher Dowdy, Fabio Ghezzi, Peter B. Makdisi, Gary Keeney, Michael J. Link, Andrea Mariani

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Objective: To present a series of brain metastases from endometrial cancer (EC) and describe a comprehensive review of the literature. Methods: We retrospectively reviewed medical records of 1) patients with cerebral dissemination of EC treated at Mayo Clinic from 1984 to 2001 and 2) all patients referred for treatment of primary brain metastases after primary treatment for EC elsewhere. We also reviewed published case reports and case series describing cerebral spread of EC. Results: Among the 1632 patients treated at Mayo, 14 (0.86%) had primary brain dissemination; 4 additional referral cases were identified (total, 18 patients). In 2 cases (11.1%), diagnosis of brain metastases was made at presentation of EC; in the others, median time to development of brain metastasis was 5 (range, 1-57) months. Median survival was 57 (range, 7-118) months in patients with single cerebral metastases and no extracerebral involvement (n = 6); for the remaining 12 patients, median survival was 4 (range, 0-28) months. Among the 6 patients with single brain metastases, complete surgical excision was possible in 5; in that group, the overall survival was 64 (range, 12-118) months. We identified 98 cases of brain metastases of EC in the literature: 58 were primary cerebral metastases. Overall survival after brain dissemination was significantly higher in patients with a single metastasis without other localization and receiving multimodal treatment including surgery and whole-brain radiotherapy. Conclusions: Single primary brain metastases without extracerebral spread seem to have a relatively favorable prognosis. Aggressive multimodal treatment may include surgery and brain radiation.

Original languageEnglish (US)
JournalGynecologic Oncology
DOIs
StateAccepted/In press - Mar 11 2016

Fingerprint

Endometrial Neoplasms
Neoplasm Metastasis
Brain
Combined Modality Therapy
Survival
Medical Records
Radiotherapy
Referral and Consultation
Radiation

Keywords

  • Brain
  • Cerebral
  • Endometrial neoplasms
  • Neoplasm metastases
  • Prognosis

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Oncology

Cite this

Primary brain metastases of endometrial cancer : A report of 18 cases and review of the literature. / Uccella, Stefano; Morris, Jonathan M.; Multinu, Francesco; Cliby, William Arthur; Podratz, Karl C.; Gostout, Bobbie S.; Dowdy, Sean Christopher; Ghezzi, Fabio; Makdisi, Peter B.; Keeney, Gary; Link, Michael J.; Mariani, Andrea.

In: Gynecologic Oncology, 11.03.2016.

Research output: Contribution to journalArticle

Uccella, Stefano ; Morris, Jonathan M. ; Multinu, Francesco ; Cliby, William Arthur ; Podratz, Karl C. ; Gostout, Bobbie S. ; Dowdy, Sean Christopher ; Ghezzi, Fabio ; Makdisi, Peter B. ; Keeney, Gary ; Link, Michael J. ; Mariani, Andrea. / Primary brain metastases of endometrial cancer : A report of 18 cases and review of the literature. In: Gynecologic Oncology. 2016.
@article{bc5dd46d4af64e6dac782701b120c4cb,
title = "Primary brain metastases of endometrial cancer: A report of 18 cases and review of the literature",
abstract = "Objective: To present a series of brain metastases from endometrial cancer (EC) and describe a comprehensive review of the literature. Methods: We retrospectively reviewed medical records of 1) patients with cerebral dissemination of EC treated at Mayo Clinic from 1984 to 2001 and 2) all patients referred for treatment of primary brain metastases after primary treatment for EC elsewhere. We also reviewed published case reports and case series describing cerebral spread of EC. Results: Among the 1632 patients treated at Mayo, 14 (0.86{\%}) had primary brain dissemination; 4 additional referral cases were identified (total, 18 patients). In 2 cases (11.1{\%}), diagnosis of brain metastases was made at presentation of EC; in the others, median time to development of brain metastasis was 5 (range, 1-57) months. Median survival was 57 (range, 7-118) months in patients with single cerebral metastases and no extracerebral involvement (n = 6); for the remaining 12 patients, median survival was 4 (range, 0-28) months. Among the 6 patients with single brain metastases, complete surgical excision was possible in 5; in that group, the overall survival was 64 (range, 12-118) months. We identified 98 cases of brain metastases of EC in the literature: 58 were primary cerebral metastases. Overall survival after brain dissemination was significantly higher in patients with a single metastasis without other localization and receiving multimodal treatment including surgery and whole-brain radiotherapy. Conclusions: Single primary brain metastases without extracerebral spread seem to have a relatively favorable prognosis. Aggressive multimodal treatment may include surgery and brain radiation.",
keywords = "Brain, Cerebral, Endometrial neoplasms, Neoplasm metastases, Prognosis",
author = "Stefano Uccella and Morris, {Jonathan M.} and Francesco Multinu and Cliby, {William Arthur} and Podratz, {Karl C.} and Gostout, {Bobbie S.} and Dowdy, {Sean Christopher} and Fabio Ghezzi and Makdisi, {Peter B.} and Gary Keeney and Link, {Michael J.} and Andrea Mariani",
year = "2016",
month = "3",
day = "11",
doi = "10.1016/j.ygyno.2016.04.013",
language = "English (US)",
journal = "Gynecologic Oncology",
issn = "0090-8258",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Primary brain metastases of endometrial cancer

T2 - A report of 18 cases and review of the literature

AU - Uccella, Stefano

AU - Morris, Jonathan M.

AU - Multinu, Francesco

AU - Cliby, William Arthur

AU - Podratz, Karl C.

AU - Gostout, Bobbie S.

AU - Dowdy, Sean Christopher

AU - Ghezzi, Fabio

AU - Makdisi, Peter B.

AU - Keeney, Gary

AU - Link, Michael J.

AU - Mariani, Andrea

PY - 2016/3/11

Y1 - 2016/3/11

N2 - Objective: To present a series of brain metastases from endometrial cancer (EC) and describe a comprehensive review of the literature. Methods: We retrospectively reviewed medical records of 1) patients with cerebral dissemination of EC treated at Mayo Clinic from 1984 to 2001 and 2) all patients referred for treatment of primary brain metastases after primary treatment for EC elsewhere. We also reviewed published case reports and case series describing cerebral spread of EC. Results: Among the 1632 patients treated at Mayo, 14 (0.86%) had primary brain dissemination; 4 additional referral cases were identified (total, 18 patients). In 2 cases (11.1%), diagnosis of brain metastases was made at presentation of EC; in the others, median time to development of brain metastasis was 5 (range, 1-57) months. Median survival was 57 (range, 7-118) months in patients with single cerebral metastases and no extracerebral involvement (n = 6); for the remaining 12 patients, median survival was 4 (range, 0-28) months. Among the 6 patients with single brain metastases, complete surgical excision was possible in 5; in that group, the overall survival was 64 (range, 12-118) months. We identified 98 cases of brain metastases of EC in the literature: 58 were primary cerebral metastases. Overall survival after brain dissemination was significantly higher in patients with a single metastasis without other localization and receiving multimodal treatment including surgery and whole-brain radiotherapy. Conclusions: Single primary brain metastases without extracerebral spread seem to have a relatively favorable prognosis. Aggressive multimodal treatment may include surgery and brain radiation.

AB - Objective: To present a series of brain metastases from endometrial cancer (EC) and describe a comprehensive review of the literature. Methods: We retrospectively reviewed medical records of 1) patients with cerebral dissemination of EC treated at Mayo Clinic from 1984 to 2001 and 2) all patients referred for treatment of primary brain metastases after primary treatment for EC elsewhere. We also reviewed published case reports and case series describing cerebral spread of EC. Results: Among the 1632 patients treated at Mayo, 14 (0.86%) had primary brain dissemination; 4 additional referral cases were identified (total, 18 patients). In 2 cases (11.1%), diagnosis of brain metastases was made at presentation of EC; in the others, median time to development of brain metastasis was 5 (range, 1-57) months. Median survival was 57 (range, 7-118) months in patients with single cerebral metastases and no extracerebral involvement (n = 6); for the remaining 12 patients, median survival was 4 (range, 0-28) months. Among the 6 patients with single brain metastases, complete surgical excision was possible in 5; in that group, the overall survival was 64 (range, 12-118) months. We identified 98 cases of brain metastases of EC in the literature: 58 were primary cerebral metastases. Overall survival after brain dissemination was significantly higher in patients with a single metastasis without other localization and receiving multimodal treatment including surgery and whole-brain radiotherapy. Conclusions: Single primary brain metastases without extracerebral spread seem to have a relatively favorable prognosis. Aggressive multimodal treatment may include surgery and brain radiation.

KW - Brain

KW - Cerebral

KW - Endometrial neoplasms

KW - Neoplasm metastases

KW - Prognosis

UR - http://www.scopus.com/inward/record.url?scp=84964691684&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84964691684&partnerID=8YFLogxK

U2 - 10.1016/j.ygyno.2016.04.013

DO - 10.1016/j.ygyno.2016.04.013

M3 - Article

JO - Gynecologic Oncology

JF - Gynecologic Oncology

SN - 0090-8258

ER -